For instance, high BMI boosts Interleukin-6 and tumor necrosis factor production, triggering hepatic inflammation and activating the oncogenic transcription factor STAT3 (signal transducer and activator of transcription 3), thereby driving liver cancer progression (51). This evidence concerns the gene STAT3 and liver cancer.